Dallah Health Holding Co., active in the operation and management of hospitals and medical clinics, reported SAR 85.1m net profit at the end of I3 of 2013, a 15% decrease compared to the same period last year, as shown in the following table:
Item | 9m 2012 | 9m 2013 | Change |
---|---|---|---|
Revenues | 457.63 | 538.61 | 17.7 % |
Gross Income | 205.56 | 231.74 | 12.7 % |
Operating Income | 98.57 | 90.52 | (8.2 %) |
Net Income | 98.99 | 84.52 | (14.6 %) |
Average Shares | 90.00 | 90.00 | - |
EPS (Riyals) | 1.10 | 0.94 | (14.6 %) |
Item | Q3 2012 | Q3 2013 | Change |
---|---|---|---|
Revenues | 142.26 | 167.08 | 17.4 % |
Gross Income | 59.00 | 66.67 | 13.0 % |
Operating Income | 22.41 | 21.95 | (2.0 %) |
Net Income | 23.94 | 21.84 | (8.7 %) |
Average Shares | 90.00 | 90.00 | - |
EPS (Riyals) | 0.27 | 0.24 | (8.7 %) |
Period | Revenues | Change | Gross Income | Change | Operating Income | Change |
---|---|---|---|---|---|---|
Q1 2013 | 183.73 | 19.3 % | 84.40 | 15.9 % | 38.39 | 1.0 % |
Q2 2013 | 187.79 | 16.4 % | 80.68 | 9.4 % | 30.19 | (20.9 %) |
Q3 2013 | 167.08 | 17.4 % | 66.67 | 13.0 % | 21.95 | (2.0 %) |
Period | Net Income | Change | EPS(Riyal) | Extraordinary Income/Expense | Net Profit Before Unusual Items | EPS Before XO Items |
---|---|---|---|---|---|---|
Q1 2013 | 39.04 | 2.8 % | 0.43 | - | 39.04 | 0.43 |
Q2 2013 | 23.64 | (36.3 %) | 0.26 | - | 23.64 | 0.26 |
Q3 2013 | 21.84 | (8.7 %) | 0.24 | - | 21.84 | 0.24 |
Period | Gross Margin | OIBDA Margin | Net Margin Before Unusual Items |
---|---|---|---|
Q1 2013 | 44.79 % | 24.18 % | 20.16 % |
Q2 2013 | 44.08 % | 22.36 % | 17.45 % |
Q3 2013 | 43.63 % | 21.80 % | 16.56 % |
Period | Shares Outstanding (M) | EPS (Riyal) | Adjusted EPS (Riyal) | Book Value (BV) |
---|---|---|---|---|
Q1 2013 | 90.00 | 1.49 | 1.49 | 12.83 |
Q2 2013 | 90.00 | 1.34 | 1.34 | 12.37 |
Q3 2013 | 90.00 | 1.32 | 1.32 | 12.64 |
Period | P/E | Adjusted P/E | Price/book |
---|---|---|---|
Q1 2013 | 23.15 | 23.15 | 2.70 |
Q2 2013 | 26.26 | 26.26 | 2.85 |
Q3 2013 | 26.93 | 26.93 | 2.82 |
Q3 2013
Period | Medical Services | Medicine and Pharmaceutical Products |
---|---|---|
Q1 2013 | 169.97 | 13.76 |
Q2 2013 | 168.24 | 19.56 |
Q3 2013 | 158.17 | 8.92 |
Current | |
Market Cap (M Riyal) | 15,452.98 |
Enterprise Value (EV) (M) | 17,372.58 |
Shares Outstanding ((M)) | 97.68 |
EPS ( Riyal) (TTM) | 4.54 |
Book Value (BV) ( Riyal) | 34.51 |
Par Value ( Riyal) | 10.00 |
Adjusted P/E (Last12) | 34.83 |
P/E (TTM) | 34.83 |
Price/book | 4.58 |
Return on Average Assets (%) (TTM) | 7.1 |
Return on Average Equity (%) (TTM) | 13.6 |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}